Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale
Background and Purpose: The International Movement Disorder Society revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used in the assessment of the severity of Parkinson’s disease (PD). This study aimed to validate the Kazakh version of the MDS-UPDRS, explore its dimensi...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Clinical Parkinsonism & Related Disorders |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259011252400001X |
| _version_ | 1797356052872691712 |
|---|---|
| author | Saltanat Abdraimova Zhanybek Myrzayev Altynay Karimova Altynay Talgatkyzy Talgat Khaibullin Gulnaz Kaishibayeva Sandugash Elubaeva Karlygash Esembekova Dongrak Choi Pablo Martinez-Martin Christopher G. Goetz Glenn T. Stebbins Sheng Luo Chingiz Shashkin Nazira Zharkinbekova Rauan Kaiyrzhanov |
| author_facet | Saltanat Abdraimova Zhanybek Myrzayev Altynay Karimova Altynay Talgatkyzy Talgat Khaibullin Gulnaz Kaishibayeva Sandugash Elubaeva Karlygash Esembekova Dongrak Choi Pablo Martinez-Martin Christopher G. Goetz Glenn T. Stebbins Sheng Luo Chingiz Shashkin Nazira Zharkinbekova Rauan Kaiyrzhanov |
| author_sort | Saltanat Abdraimova |
| collection | DOAJ |
| description | Background and Purpose: The International Movement Disorder Society revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used in the assessment of the severity of Parkinson’s disease (PD). This study aimed to validate the Kazakh version of the MDS-UPDRS, explore its dimensionality, and compare it to the original English version. Methods: The validation was conducted in three phases: first, the English version of the MDS-UPDRS was translated into Kazakh and thereafter back-translated into English by two independent teams; second, the Kazakh version underwent a cognitive pretesting; third, the Kazakh version was tested in 360 native Kazakh-speaking PD patients. Both confirmatory and exploratory factor analyses were performed to validate the scale. We calculated the comparative fit index (CFI) for confirmatory factor analysis and used unweighted least squares for exploratory factor analysis. Results: The CFI was higher than 0.90 for all parts of the scale, thereby meeting the pre-set threshold for the official designation of a validated translation. Exploratory factor analysis also showed that the Kazakh MDS-UPDRS has the analogous factors structure in each part as the English version. Conclusions: The Kazakh MDS-UPDRS had a consistent overall structure as the English MDS-UPDRS, and it was designated as the official Kazakh MDS-UPDRS, which can reliably be used in the Kazakh-speaking populations. Presently, Kazakhstan stands as the sole country in both Central Asia and Transcaucasia with an MDS-approved translated version of the MDS-UPDRS. We expect that other Central Asian and Transcaucasian countries will embark on the MDS Translation Program for MDS-UPDRS in the near future. |
| first_indexed | 2024-03-08T14:20:59Z |
| format | Article |
| id | doaj.art-496a5217de4d4eaa9b12774c741e89d4 |
| institution | Directory Open Access Journal |
| issn | 2590-1125 |
| language | English |
| last_indexed | 2024-03-08T14:20:59Z |
| publishDate | 2024-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Clinical Parkinsonism & Related Disorders |
| spelling | doaj.art-496a5217de4d4eaa9b12774c741e89d42024-01-14T05:39:47ZengElsevierClinical Parkinsonism & Related Disorders2590-11252024-01-0110100232Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scaleSaltanat Abdraimova0Zhanybek Myrzayev1Altynay Karimova2Altynay Talgatkyzy3Talgat Khaibullin4Gulnaz Kaishibayeva5Sandugash Elubaeva6Karlygash Esembekova7Dongrak Choi8Pablo Martinez-Martin9Christopher G. Goetz10Glenn T. Stebbins11Sheng Luo12Chingiz Shashkin13Nazira Zharkinbekova14Rauan Kaiyrzhanov15South Kazakhstan Medical Academy, Department of Neurology, Psychiatry, Rehabilitology and Neurosurgery, Shymkent, KazakhstanInternational Research Institute of Postgraduate Education, Department of Neurosurgery and Neurology, Almaty, KazakhstanKazakh National University n.a. Al-Farabi, Department of Biomedicine, Biophysics and Neuroscience, Almaty, Kazakhstan“Semey Medical University”, Department of Neurology, Ophthalmology, and Otorhinolaryngology, Semey, Kazakhstan“Semey Medical University”, Department of Neurology, Ophthalmology, and Otorhinolaryngology, Semey, KazakhstanInstitute of Neurology and Neurorehabilitation n.a. Smagul Kaishibayev, Almaty, KazakhstanNazarbayev University, Graduate School of Education (NU GSE), Educational Leadership (School Education), Astana, KazakhstanNazarbayev Intellectual School of Physics and Mathematics, Semey, KazakhstanDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC, USACenter for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, SpainDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USADepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USADepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC, USAInternational Research Institute of Postgraduate Education, Department of Neurosurgery and Neurology, Almaty, KazakhstanSouth Kazakhstan Medical Academy, Department of Neurology, Psychiatry, Rehabilitology and Neurosurgery, Shymkent, KazakhstanSouth Kazakhstan Medical Academy, Department of Neurology, Psychiatry, Rehabilitology and Neurosurgery, Shymkent, Kazakhstan; Institute of Neurology, University College London, Department of Neuromuscular Disorders, Queen Square, London, UK; Corresponding author at: Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.Background and Purpose: The International Movement Disorder Society revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used in the assessment of the severity of Parkinson’s disease (PD). This study aimed to validate the Kazakh version of the MDS-UPDRS, explore its dimensionality, and compare it to the original English version. Methods: The validation was conducted in three phases: first, the English version of the MDS-UPDRS was translated into Kazakh and thereafter back-translated into English by two independent teams; second, the Kazakh version underwent a cognitive pretesting; third, the Kazakh version was tested in 360 native Kazakh-speaking PD patients. Both confirmatory and exploratory factor analyses were performed to validate the scale. We calculated the comparative fit index (CFI) for confirmatory factor analysis and used unweighted least squares for exploratory factor analysis. Results: The CFI was higher than 0.90 for all parts of the scale, thereby meeting the pre-set threshold for the official designation of a validated translation. Exploratory factor analysis also showed that the Kazakh MDS-UPDRS has the analogous factors structure in each part as the English version. Conclusions: The Kazakh MDS-UPDRS had a consistent overall structure as the English MDS-UPDRS, and it was designated as the official Kazakh MDS-UPDRS, which can reliably be used in the Kazakh-speaking populations. Presently, Kazakhstan stands as the sole country in both Central Asia and Transcaucasia with an MDS-approved translated version of the MDS-UPDRS. We expect that other Central Asian and Transcaucasian countries will embark on the MDS Translation Program for MDS-UPDRS in the near future.http://www.sciencedirect.com/science/article/pii/S259011252400001XMDS-UPDRSParkinson’s DiseaseRating scaleValidation |
| spellingShingle | Saltanat Abdraimova Zhanybek Myrzayev Altynay Karimova Altynay Talgatkyzy Talgat Khaibullin Gulnaz Kaishibayeva Sandugash Elubaeva Karlygash Esembekova Dongrak Choi Pablo Martinez-Martin Christopher G. Goetz Glenn T. Stebbins Sheng Luo Chingiz Shashkin Nazira Zharkinbekova Rauan Kaiyrzhanov Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale Clinical Parkinsonism & Related Disorders MDS-UPDRS Parkinson’s Disease Rating scale Validation |
| title | Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale |
| title_full | Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale |
| title_fullStr | Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale |
| title_full_unstemmed | Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale |
| title_short | Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale |
| title_sort | validation of the kazakh version of the movement disorder society unified parkinson s disease rating scale |
| topic | MDS-UPDRS Parkinson’s Disease Rating scale Validation |
| url | http://www.sciencedirect.com/science/article/pii/S259011252400001X |
| work_keys_str_mv | AT saltanatabdraimova validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT zhanybekmyrzayev validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT altynaykarimova validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT altynaytalgatkyzy validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT talgatkhaibullin validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT gulnazkaishibayeva validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT sandugashelubaeva validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT karlygashesembekova validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT dongrakchoi validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT pablomartinezmartin validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT christopherggoetz validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT glenntstebbins validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT shengluo validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT chingizshashkin validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT nazirazharkinbekova validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale AT rauankaiyrzhanov validationofthekazakhversionofthemovementdisordersocietyunifiedparkinsonsdiseaseratingscale |